Ji Min Weixin Group announced on August 6th, with the well-known investment agency in Industry, Yinfa, Yunfeng, Yingke Capital, participated in Beijing Leisure Guardian Biotechnology Co., Ltd. (Abbreviation: Recreational Guard) pre-ipo Round financing.
At present, the domestic vaccine industry welcomes the development of the golden period, the consumption upgrade drove the booming vaccine market. The HPV market demand is strong, and domestic replacement is in the starting stage.
This Ji Min believes in the reunion guards based on its robust planning layout, outstanding research and development capabilities and good development trends.
The trivalent HPV and nine-vivo HPV vaccines have entered the clinical III, and they are ready. At the same time, it also has a recombinant double price new crown virus vaccine, and the market scale of recombinant Novirological vaccine is not less than $ 1 billion. Ji Min We will expect its products to be listed soon, benefiting more applicable people around the world. Recreation Guard said that the fundraising will be used in the recombinant human papillomavirus (HPV) trivalent (16/18/58) vaccine, recombinant human papillomavirus (HPV) nine price (6/11/16/18 / 31/33/45/52/58 type) vaccine clinical research fee, Kunming vaccine industry base construction fee, recombinant Novoli virus vaccine and recombinant new crown virus vaccine pre-clinical research cost, and other preclinical research costs before studying products and Supplementary liquidity.